Smrkolj V, Princic I
Acta Chir Iugosl. 1979;26(1):43-8.
The authors have attempted to cast some light on a problem that has confronted the surgeon for some 200 years: should a patient with terminal cancer, bone metastases and pathological fractures be treated surgically? In recent years the number of patient with pathological fractures has paralelled the increase in incidences of malignancies. Such pathological fractures are being noted at ever younger age. This paper concerns the author's five year experience with 53 patients operated on for pathological fractures at the Trauma Clinic in Ljubljana. The type of therapy chosen was determined jointly by the surgeon and oncologist strictly on an individual basis. The survival time of patients following surgery for pathological fractures was relatively long (especially with breast cancer patients /21 months postoperatively). This disprooves the thought that pathological fractures signify the beginning of the terminal phase of patients with malignancies. The authors note that the fracture to be operated on must be fixed and stable and the patients general condition of course must be permitting.
作者试图阐明一个困扰外科医生约200年的问题：对于患有晚期癌症、骨转移和病理性骨折的患者，是否应进行手术治疗？近年来，病理性骨折患者的数量与恶性肿瘤发病率的上升同步。此类病理性骨折在越来越年轻的患者中被发现。本文介绍了作者在卢布尔雅那创伤诊所对53例因病理性骨折接受手术的患者的五年经验。所选择的治疗方式由外科医生和肿瘤学家严格根据个体情况共同决定。病理性骨折手术后患者的生存时间相对较长（尤其是乳腺癌患者，术后21个月）。这反驳了病理性骨折意味着恶性肿瘤患者进入终末期的观点。作者指出，需要手术治疗的骨折必须固定且稳定，当然患者的一般状况也必须允许。
